Avoro Capital Advisors LLC Q1 2023 Filing
Filed May 15, 2023
Portfolio Value
$6745.2T
Holdings
39
Report Date
Q1 2023
Filing Type
13F-HR
All Holdings (39 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | HZNPHORIZON THERAPEUTICS PLC | 7,000,000 | $764.0T | 11.33% | |
| 2 | APLSAPELLIS PHARMACEUTICALS INC | 11,111,111 | $732.9T | 10.87% | |
| 3 | UTHUNITED THERAPEUTICS CORP | 2,870,000 | $642.8T | 9.53% | |
| 4 | SRPTSAREPTA THERAPEUTICS INC | 3,900,000 | $506.8T | 7.51% | Call |
| 5 | ARGXARGENX SE | 1,287,500 | $479.7T | 7.11% | |
| 6 | MDGLMADRIGAL PHARMACEUTICALS INC | 1,666,666 | $403.8T | 5.99% | |
| 7 | BMRNBIOMARIN PHARMACEUTICAL INC | 3,945,000 | $383.6T | 5.69% | |
| 8 | SGENUSDSEAGEN INC | 1,801,906 | $364.8T | 5.41% | |
| 9 | ASNDASCENDIS PHARMA | 3,325,000 | $356.5T | 5.29% | |
| 10 | AM6AMICUS THERAPEUTICS INC | 27,300,000 | $302.8T | 4.49% | |
| 11 | ALNYALNYLAM PHARMACEUTICALS INC | 1,105,000 | $221.4T | 3.28% | |
| 12 | MRTXEURMIRATI THERAPEUTICS INC | 5,555,555 | $206.6T | 3.06% | |
| 13 | XENEXENON PHARMACEUTICALS INC | 4,900,000 | $175.4T | 2.60% | |
| 14 | OPHTEURIVERIC BIO INC | 7,675,000 | $167.3T | 2.48% | Call |
| 15 | KRYSKRYSTAL BIOTECH INC | 1,750,000 | $140.1T | 2.08% | |
| 16 | KYMRKYMERA THERAPEUTICS INC | 3,855,000 | $114.2T | 1.69% | |
| 17 | —DICE THERAPEUTICS INC | 3,950,000 | $113.2T | 1.68% | |
| 18 | CBAYUSDCYMABAY THERAPEUTICS INC | 10,300,000 | $89.8T | 1.33% | |
| 19 | BCRXBIOCRYST PHARMACEUTICALS INC | 10,420,000 | $86.9T | 1.29% | |
| 20 | SNDXSYNDAX PHARMACEUTICALS INC | 2,650,000 | $56.0T | 0.83% | |
| 21 | NUVLNUVALENT INC | 1,888,888 | $49.3T | 0.73% | |
| 22 | IOVAIOVANCE BIOTHERAPEUTICS INC | 7,020,000 | $42.9T | 0.64% | |
| 23 | RNAAVIDITY BIOSCIENCES INC | 2,510,000 | $38.5T | 0.57% | |
| 24 | KURAKURA ONCOLOGY INC | 3,105,000 | $38.0T | 0.56% | |
| 25 | MNKDMANNKIND CORP | 9,100,000 | $37.3T | 0.55% | |
| 26 | GLUEMONTE ROSA THERAPEUTICS INC | 4,325,000 | $33.7T | 0.50% | |
| 27 | —MERSANA THERAPEUTICS INC | 7,550,000 | $31.0T | 0.46% | |
| 28 | RAREULTRAGENYX PHARMACEUTICAL INC | 750,000 | $30.1T | 0.45% | |
| 29 | MRNS*MARINUS PHARMACEUTICALS INC | 3,150,000 | $21.7T | 0.32% | |
| 30 | WHWKAADI BIOSCIENCES INC | 2,849,402 | $20.6T | 0.31% | |
| 31 | DSGNDESIGN THERAPEUTICS INC | 3,500,000 | $20.2T | 0.30% | |
| 32 | VRCAVERRICA PHARMACEUTICALS INC | 2,650,000 | $17.2T | 0.26% | |
| 33 | PMVPPMV PHARMACEUTICALS INC | 3,060,000 | $14.6T | 0.22% | |
| 34 | AMLXAMYLYX PHARMACEUTICALS INC | 473,100 | $13.9T | 0.21% | |
| 35 | FRXFENNEC PHARMACEUTICALS INC | 1,200,000 | $10.0T | 0.15% | |
| 36 | MCRB1EURSERES THERAPEUTICS INC | 1,295,000 | $7.3T | 0.11% | |
| 37 | TNGXTANGO THERAPEUTICS INC | 1,640,000 | $6.5T | 0.10% | |
| 38 | IOBTIO BIOTECH INC | 2,055,883 | $3.8T | 0.06% | |
| 39 | XBISPDR SERIES TRUST - S&P BIOTECH | 1,500,000 | $180.0B | 0.00% | Call |